Skip to main content

International Diabetes Center research helps pave way for
FDA approval of device to help type 1 diabetics


September 28, 2016


BLOOMINGTON, Minn. – The U.S. Food and Drug and Administration (FDA) today approved a device that will change the lives of people living with type 1 diabetes. The International Diabetes Center (IDC) led the groundbreaking research that helped Medtronic get approval of the first Hybrid Closed Loop system. It’s often referred to as the artificial pancreas.

The Hybrid Closed Loop system constantly monitors the blood sugar and automatically adjusts the insulin being delivered to individuals with type 1 diabetes. It delivers more insulin when the sugar level is going up and less insulin when the sugar is headed down. It helps smooth out the blood sugar levels overall.

“Our researchers led clinical trials of the artificial pancreas and published the results showing the system is both safe and effective,” said IDC Executive Director Richard Bergenstal, MD.

This will be the first device of its kind available to patients. It’s expected to be available commercially next year.

“The system allows patients to improve the control of their diabetes without having to spend every hour of the day worrying about it,“ Bergenstal explained.

Bergenstal reacts to FDA approval.

About International Diabetes Center

Founded by Donnell D. Etzwiler, MD, in 1967, IDC provides world-class diabetes care, education, publications and research that meet the needs of people with diabetes and their families. It includes more than 80 health care professionals involved in research and education, along with the collaboration of professionals across the HealthPartners Park Nicollet care system to ensure patients receive the best possible diabetes care.

IDC is part of HealthPartners Institute. One of the largest medical research and education centers in the Midwest, the Institute conducts more than 450 research studies annually; trains medical residents, fellows and students; and provides continuing medical education, patient education and clinical quality improvement.

Back to top